ArticleOncotarget2018

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells.

Miao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.